Tag Archive for ‘national clinical trials’
This month’s column provides an update on the ALCHEMIST trials for patients with operable lung cancer, including the addition of a third arm to study, which permits the inclusion of patients without ALK or EGFR mutations.
A new approach for advanced gastric cancer: Using PET scans as a biomarker of preoperative chemotherapy efficacy
This month’s column describes how new technology may improve outcomes for patients diagnosed with gastric cancer, specifically the use of PET scans as a biomarker of preoperative chemotherapy efficacy.
Research findings regarding the effect of metabolic response on gastric cancer are summarized, including the new Alliance 021302 trial.
The primary outcome of the Z6051 rectal cancer trial is outlined in this month’s column as are new surgical trial concepts that resulted from this study.
The PROSPECT trial for individualized treatment is discussed in this month’s column as is the surgeon’s role in ensuring the success of this trial.
Enrolling patients into national clinical trials—particularly patients from community cancer centers—is necessary to advance the science and treatment of cancer care.